Our Testosterone Therapy Attorneys are offering Free Case Evaluations for men who were prescribed low testosterone therapy drugs, who suffered heart problems while being treated for Low-T. Serious side effects associated with these products include heart attack, stroke, and in some cases, death.
Testosterone therapy lawsuits are becoming more frequent as thousands of men are reporting side effects during treatment. New research has shown an associated increased risk of complications in men that have had testosterone therapy. The products, intended as a supplemental therapy for men with low testosterone levels, could lead to increased risk of heart attack, stroke, blood clots, or possibly death.
If you or a loved one were prescribed a testosterone product and suffered a suffered cardiovascular side effects such as a heart attack, stroke, blood clots, or death; contact the experienced attorneys at Gary Logsdon & Associates now to get your FREE case consultation.
On January 31, 2014, the U.S. Food and Drug Administration (FDA) released a safety announcement warning consumers of the potential risk of testosterone therapy. The FDA announced that they will be conducting further investigation into several testosterone therapy products. Concern arose from two published studies that suggest a higher risk of adverse side effects.
These testosterone therapy products have been marketed to men with no adequate warning labels of medical complications. Our law firm believes that the manufacturers of these products may not have adequately warned doctors or their patients of the increased risk for significant cardiovascular side effects. The manufacturers of these products may be liable for the injuries and any wrongful deaths resulting from the use of testosterone therapy products.
The defendants currently include Abbott, AbbVie, Auxilium Pharmaceuticals, Pfizer, and Pharmacia & Upjohn. Plaintiffs’ attorneys predict the number of testosterone lawsuits will number in the thousands.
In issuing its order, the panel stated: “All actions involve plaintiffs (or their survivors) who used one or more testosterone replacement therapies and contend that their (or their decedent’s) use of the drugs caused their injuries, which include heart attack, stroke, deep vein thrombosis, and pulmonary embolism. All testosterone replacement therapy actions will share factual questions regarding general causation and the background science regarding the role of testosterone in the aging body … as well as involve common regulatory issues in light of the FDA’s announcement and subsequent actions, if any.”